ZYMERON CORPORATION — Department of Health and Human Services SBIR Phase I: 87
ZYMERON CORPORATION — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $299,988
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 87
- Solicitation
- PHS2021-1
- NAICS
- —
- Place of performance
- NC
- Period
- —
Description
The goal is to develop novel, low-cost, real-time point-of-care (POC) assays for antiretroviral drug adherence monitoring: - Rapid point-of-care methods that measure long-term (rt 7 days) adherence to antiretroviral drugs - Ability to measure drug levels in various biological matrices, e.g., urine, hair, dried blood spots, etc. - Ability to monitor PrEP adherence, ART adherence to trigger adherence interventions, the long-tail associated with long-acting ART or PrEP, and blood donations for PrEP or ART drug levels (as a risk indicator of HIV exposure or infection)